Latest Breaking News On - Coeptis pharmaceuticals - Page 4 : comparemela.com

Coeptis Therapeutics Announces Deverra Therapeutics Has Received Two Life Science Start-Up and Development Awards and Associated Grant from Washington s Cancer Research Endowment

Coeptis Therapeutics Announces Deverra Therapeutics Has Received Two Life Science Start-Up and Development Awards and Associated Grant from Washington s Cancer Research Endowment
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

District of columbiaUnited statesDave mehalickDavid schemeliaDaniel kontoh boatengKarolinska institutetCoeptis therapeutics incExchange commissionCoeptis therapeutics holdings incWashington cancer research endowmentDrug administrationAndy hill cancer research endowmentSecurities exchangePrnewswire coeptis therapeutics holdings incCoeptis pharmaceuticals incHoldings inc

Coeptis Therapeutics Appoints Colleen Delaney, MD, as Chief Scientific and Medical Officer

/PRNewswire/ Coeptis Therapeutics Holdings, Inc. (NASDAQ: COEP) ("Coeptis" or "the Company"), a biopharmaceutical company developing innovative cell therapy.

Karolinska institutetFred hutchMadeline dabney adamsColleen delaneyDave mehalickDaniel kontoh boatengUniversity of pittsburghDrug administrationHarvard medical schoolDivision of pediatric hematology oncologyOxford universityUniversity of washingtonPrnewswire coeptis therapeutics holdings incSecurities exchangeCoeptis therapeutics holdings incCoeptis therapeutics inc

Coeptis Therapeutics Completes Exclusive License for Allogeneic Immuno-Oncology Platform and Clinical Stage Assets from Deverra Therapeutics

/PRNewswire/ Coeptis Therapeutics Holdings, Inc. (NASDAQ: COEP) ("Coeptis" or "the Company"), a biopharmaceutical company developing innovative cell therapy.

Colleen delaneyKarolinska institutetDave mehalickDaniel kontoh boatengExchange commissionCoeptis therapeutics holdings incCoeptis pharmaceuticals incUniversity of pittsburghHoldings incCoeptis therapeutics incDeverra therapeutics incSecurities exchangeDrug administrationCoeptis therapeutics holdingsDeverra therapeuticsInvestigational new drug

Coeptis Therapeutics Holdings, Inc Announces Closing of $3 5 Million Underwritten Offering

Coeptis Therapeutics Holdings, Inc Announces Closing of $3 5 Million Underwritten Offering
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesDaniel kontoh boatengDavid schemeliaKarolinska institutetCoeptis therapeutics holdings incProspectus departmentDrug administrationUniversity of pittsburghLadenburg thalmann coCoeptis therapeutics incCoeptis pharmaceuticals incSecurities exchangeHoldings incExchange commissionPrnewswire coeptis therapeutics holdings inc

Coeptis Therapeutics Holdings, Inc Announces Closing of $3 5 Million Underwritten Offering

/PRNewswire/ Coeptis Therapeutics Holdings, Inc. (NASDAQ: COEP) ("Coeptis" or the "Company"), a biopharmaceutical company developing innovative cell therapy.

New yorkUnited statesDaniel kontoh boatengDavid schemeliaKarolinska institutetExchange commissionProspectus departmentDrug administrationCoeptis therapeutics incCoeptis pharmaceuticals incSecurities exchangePrnewswire coeptis therapeutics holdings incHoldings incCoeptis therapeutics holdings incLadenburg thalmann coUniversity of pittsburgh